Cargando…
Toxicity‐dependent feasibility bounds for the escalation with overdose control approach in phase I cancer trials
Phase I trials of anti‐cancer therapies aim to identify a maximum tolerated dose (MTD), defined as the dose that causes unacceptable toxicity in a target proportion of patients. Both rule‐based and model‐based methods have been proposed for MTD recommendation. The escalation with overdose control (E...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5462100/ https://www.ncbi.nlm.nih.gov/pubmed/28295513 http://dx.doi.org/10.1002/sim.7280 |